Accelerated Biological Aging is Associated With Increased Risk of T2DM in the MASLD Population

This study is a retrospective data analysis (using existing health records, not enrolling new patients actively) that looks at whether biological aging — measured through blood test markers — is linked to a higher risk of developing type 2 diabetes in people who have metabolic-associated steatotic liver disease (MASLD, previously called non-alcoholic fatty liver disease). The goal is to better understand how aging biology contributes to diabetes risk. **You may be eligible if your records are included if...** - You had abdominal ultrasound data available from routine health check-ups - At least one standard metabolic measurement (BMI, blood pressure, triglycerides, HDL, or blood sugar) was recorded annually - You are between 20 and 90 years old at baseline **You may NOT be eligible if...** - Your liver condition was caused by alcohol or hepatitis B infection - You already had type 2 diabetes at baseline - Key baseline lab values were missing from your records Talk to your doctor to see if this study applies to you.